Back to trial details

Intake questionnaire

Ribociclib And Endocrine Treatment of Physician's Choice for Locoregional Recurrent, Resected Hormone Receptor Positive HER2 Negative Breast Cancer

Applying to New York University Clinical Cancer Center · New York, New York

Answer a few short questions to share with the research team.

0 of 4 answered

1. Are you 18 years old or older?
2. Have you been diagnosed with Locoregional Recurrence?
3. Are you currently pregnant or breastfeeding?
4. Are you able to travel to New York for study visits?